首页> Leukemia> Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).

Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).

导出 LinkOut

翻译打印收藏纠错

第一作者： Frances M,Cole

第一单位： Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

作者： Frances M,Cole ^[1] ; George S,Laszlo ^[1] ; Margaret C,Lunn-Halbert ^[1] ; Allie R,Kehret ^[1] ; Patrick A,Zweidler-McKay ^[2] ; Eduardo,Rodríguez-Arbolí ^[3] ; David,Wu ^[4] ; Kyle,Nyberg ^[1] ; Junyang,Li ^[1] ; Sheryl Y T,Lim ^[1] ; Camryn M,Pettenger-Willey ^[1] ; Sribalaji,Lakshmikanthan ^[2] ; Roland B,Walter ^[5]

作者单位： Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. ^[1] ImmunoGen Inc, Waltham, MA, USA. ^[2] Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.;Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), University of Seville, Seville, Spain. ^[3] Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. ^[4] Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. rwalter@fredhutch.org.;Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org.;Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA. rwalter@fredhutch.org. ^[5]

DOI 10.1038/s41375-025-02571-0

PMID 40119158

发布时间 2025-05-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Leukemia

2025年39卷5期

1243-1246页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).

Leukemia

相似文献

Leukemia

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632).

Leukemia

相似文献

Leukemia

相关期刊

检索历史清除